Latest IMVT reports update at 2024-02-12: 2023-Q4 ∙ 2023-Q1 ∙ 2022-Q4

Immunovant IMVT

$ 29.7 -0.2%

Immunovant Financial Statements 2011-2024 | IMVT

Annual Financial Statements Immunovant

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	2.92 B	2.6 B	439 M	802 M	-	-	-	-	-	-	-	-	-
Shares	123 M	110 M	87.8 M	43.2 M	-	-	-	-	-	-	-	-	-
Historical Prices	23.8	23.8	5.58	15.8	15.7	-	-	-	-	-	-	-	-
Net Income	-211 M	-157 M	-107 M	-66.4 M	-	-450	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-253 K	-781 K	-	625 K	-155 K	-	-	-	-	-	-	-	-
EBITDA	193 K	126 K	65 K	-66.1 M	-	-450	-	-	-	-	-	-	-
Operating Expenses	218 M	156 M	108 M	66.1 M	-	450	-	-	-	-	-	-	-
General and Administrative Expenses	48 M	54.2 M	39.5 M	18.2 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Immunovant

	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	145 M	131 M	131 M	130 M	129 M	117 M	117 M	116 M	115 M	107 M	104 M	98 M	97.9 M	84.4 M	77.6 M	54.7 M	41 M	38.6 M	38.6 M	2.5 M	36.7 M	16.8 M	2.88 M	2.88 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-51.4 M	-58.7 M	-73.9 M	-	-63.2 M	-47.9 M	-40.4 M	-	-41.4 M	-110 M	-30.5 M	-	-31.8 M	-31.8 M	-20.8 M	-26.7 M	-11.3 M	-14.5 M	-20.1 M	-20.1 M	-8.85 M	-19.6 M	-4.37 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-420 K	-92.3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.09 M	20 K	464 K	-	-1.76 M	793 K	354 K	-	-114 K	-825 K	-711 K	-	-	-	-	-	376 K	249 K	25 K	-	43 K	-63 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	139 K	44 K	-	-	87 K	54 K	-	-	43 K	24 K	-	-	-420 K	-87.3 K	-	-	5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	61.6 M	61.8 M	78.5 M	-	64 M	49.6 M	40.4 M	-	41.3 M	109 M	67.5 M	-	31.6 M	31.6 M	21 M	-	11 M	14.5 M	20.1 M	-	8.88 M	19.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	13.2 M	13.8 M	15.4 M	-	11.8 M	11.9 M	11.9 M	-	11.5 M	39 M	27.5 M	-	10.5 M	10.5 M	9 M	-	6.09 M	4.16 M	1.58 M	-	1.2 M	1.73 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency